Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KYTHERA BIOPHARMACEUTICALS INC (KYTH)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-15Mar-31-15Dec-31-14Sep-30-14Jun-30-14Mar-31-14Dec-31-13Sep-30-13
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -37.2-28.8-24.2-22.5-19.5-69.4-14.0-11.5
Depreciation and amortization   [+]0.20.20.20.10.00.00.00.0
Stock-based compensation  6.74.43.33.23.02.91.72.1
Change in working capital   [+]4.21.836.79.32.40.228.63.4
Other operating activities  0.80.5-31.8-4.4-0.451.3-27.0-3.7
Cash from operations  -25.3-21.9-15.8-14.3-14.4-15.0-10.7-9.7
   
Capital expenditures  -0.3-0.3-0.1-1.1-0.70.00.00.0
Purchases of short-term investments, net  -47.324.46.8-27.06.9-3.0-27.13.0
Other cash from investing  -0.5       
Cash from investing  -48.124.26.7-28.26.2-3.0-27.13.0
   
Issuance of common stock, net  -135.0135.0    125.0 
Option exercises  -0.90.9 1.3-1.11.1 0.5
Other cash from financing  134.00.3-1.4-0.2-2.40.7-0.9-0.2
Cash from financing  -0.1134.3-1.4-1.4-1.3-0.3124.1-0.7
   
Free cash flow  -25.7-22.1-16.0-15.4-15.2-15.1-10.7-9.7
        Per share (diluted)  ($0.99)($0.95)($0.71)($0.68)($0.67)($0.69)($0.56)($0.52)
   
Cash paid for interest  1.6 0.10.60.4 0.30.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy